Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T63068 | Target Info | |||
Target Name | Serum albumin (ALB) | ||||
Synonyms | Serum albumin | ||||
Target Type | Successful Target | ||||
Gene Name | ALB | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | Caprylic acid | Ligand Info | |||
Canonical SMILES | CCCCCCCC(=O)O | ||||
InChI | 1S/C8H16O2/c1-2-3-4-5-6-7-8(9)10/h2-7H2,1H3,(H,9,10) | ||||
InChIKey | WWZKQHOCKIZLMA-UHFFFAOYSA-N | ||||
PubChem Compound ID | 379 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 5Z0B Crystal structure of plasma-derived human serum albumin | ||||||
Method | X-ray diffraction | Resolution | 2.17 Å | Mutation | No | [1] |
PDB Sequence |
KSEVAHRFKD
13 LGEENFKALV23 LIAFAQYLQQ33 PFEDHVKLVN44 EVTEFAKTCV54 ADESAENCDK 64 SLHTLFGDKL74 CTVATLRETY84 GEMADCCAKQ94 EPERNECFLQ104 HKDDNPNLPR 114 LVRPEVDVMC124 TAFHDNEETF134 LKKYLYEIAR144 RHPYFYAPEL154 LFFAKRYKAA 164 FTECCQAADK174 AACLLPKLDE184 LRDEGKASSA194 KQRLKCASLQ204 KFGERAFKAW 214 AVARLSQRFP224 KAEFAEVSKL234 VTDLTKVHTE244 CCHGDLLECA254 DDRADLAKYI 264 CENQDSISSK274 LKECCEKPLL284 EKSHCIAEVE294 NDEMPADLPS304 LAADFVESKD 314 VCKNYAEAKD324 VFLGMFLYEY334 ARRHPDYSVV344 LLLRLAKTYE354 TTLEKCCAAA 364 DPHECYAKVF374 DEFKPLVEEP384 QNLIKQNCEL394 FEQLGEYKFQ404 NALLVRYTKK 414 VPQVSTPTLV424 EVSRNLGKVG434 SKCCKHPEAK444 RMPCAEDYLS454 VVLNQLCVLH 464 EKTPVSDRVT474 KCCTESLVNR484 RPCFSALEVD494 ETYVPKEFNA504 ETFTFHADIC 514 TLSEKERQIK524 KQTALVELVK534 HKPKATKEQL544 KAVMDDFAAF554 VEKCCKADDK 564 ETCFAEEGKK574 LVAASQAALG584
|
|||||
|
VAL23
4.652
ALA26
4.328
PHE27
4.357
VAL46
3.621
PHE49
4.349
LEU66
4.257
LEU69
3.722
PHE70
3.506
LYS73
3.726
ARG209
4.068
LYS212
4.252
ALA213
3.683
VAL216
4.379
|
|||||
PDB ID: 6WUW Crystal structure of Human Serum Albumin complex with JMS-053 | ||||||
Method | X-ray diffraction | Resolution | 2.20 Å | Mutation | No | [2] |
PDB Sequence |
HKSEVAHRFK
12 DLGEENFKAL22 VLIAFAQYLQ32 QCPFEDHVKL42 VNEVTEFAKT52 CVADESAENC 62 DKSLHTLFGD72 KLCTVATLRE82 TYGEMADCCA92 KQEPERNECF102 LQHKDDNPNL 112 PRLVRPEVDV122 MCTAFHDNEE132 TFLKKYLYEI142 ARRHPYFYAP152 ELLFFAKRYK 162 AAFTECCQAA172 DKAACLLPKL182 DELRDEGKAS192 SAKQRLKCAS202 LQKFGERAFK 212 AWAVARLSQR222 FPKAEFAEVS232 KLVTDLTKVH242 TECCHGDLLE252 CADDRADLAK 262 YICENQDSIS272 SKLKECCEKP282 LLEKSHCIAE292 VENDEMPADL302 PSLAADFVES 312 KDVCKNYAEA322 KDVFLGMFLY332 EYARRHPDYS342 VVLLLRLAKT352 YETTLEKCCA 362 AADPHECYAK372 VFDEFKPLVE382 EPQNLIKQNC392 ELFEQLGEYK402 FQNALLVRYT 412 KKVPQVSTPT422 LVEVSRNLGK432 VGSKCCKHPE442 AKRMPCAEDY452 LSVVLNQLCV 462 LHEKTPVSDR472 VTKCCTESLV482 NRRPCFSALE492 VDETYVPKEF502 NAETFTFHAD 512 ICTLSEKERQ522 IKKQTALVEL532 VKHKPKATKE542 QLKAVMDDFA552 AFVEKCCKAD 562 DKETCFAEEG572 KKLVAASQAA582 LG
|
|||||
|
||||||
PDB ID: 5X52 Human serum albumin complexed with octanoate and N-acetyl-L-methionine | ||||||
Method | X-ray diffraction | Resolution | 3.00 Å | Mutation | No | [3] |
PDB Sequence |
HKSEVAHRFK
12 DLGEENFKAL22 VLIAFAQYLQ32 QCPFEDHVKL42 VNEVTEFAKT52 CVADESAENC 62 DKSLHTLFGD72 KLCTVATLRE82 TYGEMADCCA92 KQEPERNECF102 LQHKDDNPNL 112 PRLVRPEVDV122 MCTAFHDNEE132 TFLKKYLYEI142 ARRHPYFYAP152 ELLFFAKRYK 162 AAFTECCQAA172 DKAACLLPKL182 DELRDEGKAS192 SAKQRLKCAS202 LQKFGERAFK 212 AWAVARLSQR222 FPKAEFAEVS232 KLVTDLTKVH242 TECCHGDLLE252 CADDRADLAK 262 YICENQDSIS272 SKLKECCEKP282 LLEKSHCIAE292 VENDEMPADL302 PSLAADFVES 312 KDVCKNYAEA322 KDVFLGMFLY332 EYARRHPDYS342 VVLLLRLAKT352 YETTLEKCCA 362 AADPHECYAK372 VFDEFKPLVE382 EPQNLIKQNC392 ELFEQLGEYK402 FQNALLVRYT 412 KKVPQVSTPT422 LVEVSRNLGK432 VGSKCCKHPE442 AKRMPCAEDY452 LSVVLNQLCV 462 LHEKTPVSDR472 VTKCCTESLV482 NRRPCFSALE492 VDETYVPKEF502 NAETFTFHAD 512 ICTLSEKERQ522 IKKQTALVEL532 VKHKPKATKE542 QLKAVMDDFA552 AFVEKCCKAD 562 DKETCFAEEG572 K
|
|||||
|
LYS195
4.675
LYS199
3.474
TRP214
3.543
ARG218
3.665
LEU219
3.724
ARG222
2.965
LEU238
3.687
ARG257
3.834
LEU260
3.909
ALA261
4.671
ILE264
4.253
SER287
4.428
ILE290
3.675
ALA291
3.725
LEU387
3.862
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | The crystal structure of plasma-derived human serum albumin | ||||
REF 2 | Structure of the Complex of an Iminopyridinedione Protein Tyrosine Phosphatase 4A3 Phosphatase Inhibitor with Human Serum Albumin. Mol Pharmacol. 2020 Dec;98(6):648-657. | ||||
REF 3 | Crystallographic analysis of the ternary complex of octanoate and N-acetyl-l-methionine with human serum albumin reveals the mode of their stabilizing interactions. Biochim Biophys Acta Proteins Proteom. 2017 Aug;1865(8):979-984. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.